The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Krause B. J., Souvatzoglou M., Tuncel M., Herrmann K., Buck A. K., Praus C., ...More

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.35, no.1, pp.18-23, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 1
  • Publication Date: 2008
  • Doi Number: 10.1007/s00259-007-0581-4
  • Journal Name: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.18-23
  • Keywords: prostate cancer, PET, PET, CT, PET oncology, POSITRON-EMISSION-TOMOGRAPHY, RADICAL PROSTATECTOMY, LOCAL RECURRENCE, RADIATION-THERAPY, COMPUTED-TOMOGRAPHY, C-11-CHOLINE PET, ANTIGEN RELAPSE, DISEASE, RADIOTHERAPY, EXPERIENCE
  • Hacettepe University Affiliated: Yes

Abstract

Purpose An increase of the serum PSA-level is a sensitive in vitro marker for recurrent prostate cancer. However, it remains difficult to differentiate between local, regional or distant recurrent disease. The aim of this study was to assess the relationship between the detection rate of [C-11]Choline-PET/CT and the serum PSA-level in patients with a biochemical recurrence of prostate cancer with the view towards localisation of recurrent disease.